lecture 21 - osteoporosis Flashcards

1
Q

what is osteoporosis?

A

a disease characterised by low bone structure mass and structural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture.it is
Asymptomatic - often remains undiagnosed until a fragility fracture occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what can osteoporosis lead to ?

A

Osteoporotic fracture is a fragility fracture occurring as a consequence of osteoporosis. Characteristically, fractures occur in the wrist, spine, and hip, but they can also occur in the arm, pelvis, ribs, and other bones. it defined as a fracture following a fall from standing height or less, although vertebral fractures may occur spontaneously, or as a result of routine activities such as bending or lifting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the prevalence on osteoporosis in patients?

A

Women are at greater risk of osteoporosis due to the decrease in oestrogen production at the menopause, which accelerates bone loss.

The prevalence of osteoporosis increases markedly, from approximately 2% at 50 years of age to almost 50% at 80 years of age
In England and Wales, around 180,000 of the fractures presenting each year are the result of osteoporosis

More than one in three women and one in five men will sustain one or more osteoporotic fractures in their lifetime

White men and women are at increased risk of fragility fracture compared with other ethnic groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are causes of osteoporosis ?

A

The age when osteoporosis becomes apparent depends on:
1. Peak bone mass depends on:
* genetic factors
* levels of nutrition (particularly calcium and vitamin D)
* sex hormone levels (androgens and oestrogens)
* level of physical activity.

  1. Rate of bone loss, which depends on a number of factors including oestrogen deficiency in women and decreased testosterone in older men and hyperparathyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathophysiology of osteoporosis ?

A

Osteoporosis is the end result of an imbalance in the normal process of bone remodelling by osteoclasts and osteoblasts

osteoclasts - cells that degrade bone to initiate normal bone remodelling and mediate bone loss in pathologic conditions by increasing their resorptive activity

osteoblasts - cells that form new bone. They also come from the bone marrow and produce new bone made of bone collagen and other protein. Then they control calcium and mineral deposition, which form the bone multicellular unit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what happens during normal ageing ?

A

during normal ageing, bone breakdown by osteoclasts increases and it is not balanced by new bone formation by osteoblasts resulting in a combination of:
- reduced bone mineral density BMDI, which can be measured by dual energy X-ray absorptiometry (DXA) scanning.
- changes in bone composition, architecture, size and geometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the composition of the bone ?

A

The adult human skeleton is composed of 80% cortical bone and 20% trabecular bone overall. Different bones and skeletal sites within bones have different ratios of cortical to trabecular bone. The vertebra is composed of cortical to trabecular bone in a ratio of 25:75. This ratio is 50:50 in the femoral head and 95:5 in the radial shaft

Cortical bone is dense and solid and surrounds the marrow space, whereas trabecular bone is composed of a honeycomb-like network of trabecular plates and rods interspersed in the bone marrow compartment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what bones are affected in osteoporosis?

A

In individuals less than 65 years of age, the largest surface available for bone remodelling is the trabecular bone.

Within this population, trabecular bone – due to its lesser density when compared to cortical bone – provides only about 20% of the skeletal bone mass but responsible for most of the turnover

Bone loss in early osteoporosis is mainly a trabecular bone loss.

With increasing age, the cortical bone becomes more and more porous and, therefore the largest loss of absolute bone mass due to osteoporosis occurs in cortical bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are complications associated with osteoporosis ?

A

Osteoporotic fragility fractures may be asymptomatic: around 50–70% are clinically silent and do not come to clinical attention

Complications of osteoporosis are fragility fractures and their consequences are

hip fracture
- about 50% of people with an osteoporotic fragility fracture of the hip can no longer live independently .
- around 25% of the deaths following hip fractures are related to the fracture, and around 75% to comorbidities

and

Vertebral fracture
- can cause back pain and difficulties in bending, reaching, and other activities of daily living
- Around 30% of deaths following vertebral fractures are related (directly or indirectly) to the fracture, and around 70% to comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the risk factors for fractures?

A

The risk of getting an osteoporotic fracture depends on the person’s risk of falls, their bone strength (determined by bone mineral density [BMD]), and other risk factors.

Fracture risk increases progressively with decreasing BMD, but BMD is poorly sensitive at predicting fracture risk when used without considering other risk factors.

Factors that reduce BMD include:
- Endocrine disease including Diabetes mellitus, Hyperthyroidism, and hyperparathyroidism.
- Gastrointestinal conditions that cause malabsorption such as Crohn’s disease, Ulcerative colitis, Coeliac disease, and Pancreatitis - chronic.
- Chronic kidney or liver disease.
- Chronic obstructive pulmonary disease.
- Menopause.
- Immobility.
- Body mass index of less than 18.5 kg/m²

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are factors that reduce BMD and risk factors for falls?

A

Age - risk increases with age and is at least partly independent of BMD.

Oral corticosteroids (dependent on the dose and duration of treatment).

Smoking and smoking

Previous fragility fracture (risk increases with increasing number of fractures). Risk is highest for previous hip fractures and lowest for previous vertebral fractures.

Rheumatological conditions such as rheumatoid arthritis, and other inflammatory arthropathies.

Parental history of hip fracture.

Risk factors for falls include:
Impaired vision.

Neuromuscular weakness and incoordination.

Cognitive impairment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does a DEXA scan do?

A

Measures bone mineral density using central hip and/or spine DEXA scanning and is expressed in the number of standard deviations below peak bone mineral density.

T score- compares bone density to that of a 25 year old. The lower your score, the weaker your bones are:

T-score between -1.0 and -2.5 = low bone density, or osteopenia

T-score of -2.5 or lower = osteoporosis

Sometimes a Z score is used = compares bone density to a normal score for a person of same age and body size.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are there investigations in testing for osteoporosis ?

A

Bloods:

FBC, ESR, TSH, U+E’s, bone and LFTs.
Other tests may be used to rule out cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the role of glucorticoids in osteoporosis?

A

Modify osteoblastic cell differentiation, number, and function.

Stimulate osteoclastogenesis

Inhibit bone formation - caused by a decrease in the number of osteoblasts

Decrease the function of the remaining osteoblasts directly and indirectly through the inhibition of insulin-like growth factor I expression.

The stimulation of bone resorption is likely responsible for the initial bone loss after glucocorticoid exposure. Eventually causing a decrease in bone remodeling and a continued increased risk of fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is non pharmacological advice for patient with oesteoporosis?

A
  1. Diet.
    1000 mg Calcium daily intake for postmenopausal women →24 % reduction in hip #
    Avoid caffeinated products. Evidence inconclusive.
  2. Regular exercise. Weight bearing exercise > 30 mins/day reduce# rate.
  3. Stop smoking. Pre-menopause leads to 25 % ↓# rate postmenopausal
  4. reduce alcohol consumption to recommended intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is prescribed for bone sparing treatment?

A

if bone sparing treatment is recommended prescribe biphosphate

  • Alendroate 10mg once daily or 70mg once weekly
  • Risedronate 5mg once daily or 35mg once weekly

IF there are no contraindications and after appropriate counselling to

post menopausal women and men over 50 years which have confirmed by DXA scan to have osteoporosis BMD score of -2.5 or less

or people on high dose oral corticosteroids (more than or = to prednisolone 7.5mg daily for 3mnths or longer

17
Q

what are licensed biphosphates and specialist treatment options ?

A

All the bisphosphonates are licensed for use in postmenopausal women. However, only alendronate (once-daily tablets) and risedronate (once-weekly tablets) are licensed in men

If oral bisphosphonate is not tolerated or is contraindicated, consider specialist referral. Specialist treatment options include zoledronic acid, strontium ranelate, raloxifene, denosumab, and teriparatide.

18
Q

what is the mechanism of action of biphosphates ?

A

Bisphosphonates have a very low oral bioavailability. After administration it distributes into soft tissue and bone or is excreted in the urine no metabolism

Bisphosphonates binds to bone hydroxyapatite. Bone resorption causes local acidification, releasing the drug which is that taken into osteoclasts - where they induce apoptosis. Inhibition of osteoclasts results in decreased bone resorption

19
Q

what is the dose for alendrotnic acid?

A

women - 70mg once weekly if postmenopausal

men - 10mg daily if have osteoporosis induced by the use of corticosteroids and are not undergoing hormone replacement therapy.

20
Q

what is couselling with alendrotnic ?

A

To be swallowed whole, with water while sitting or standing on an empty stomach 30 mins before breakfast.

Pt should then stand or sit upright for at least 30 mins after taking the tablet.

Side effects:
oesophageal reactions- oesophagitis/ulcers/stricture/erosions.

21
Q

what is the criteria for taking calcium and vitamin D ?

A

If the person’s calcium intake is adequate(700 mg/day), prescribe10micrograms (400 international units) of vitaminD for people not exposed to much sunlight

If calcium intake is inadequate:
need 10micrograms (400 international units) of vitaminD with at least 1000mg of calcium daily
20micrograms (800 international units) of vitamin D with at least 1000 mg of calcium daily for elderly people who are housebound or living in a nursing home.

22
Q

describe specialist treatment: strontium ranelate

A

strontium ranelate stimulates bone formation and reduces bone resorption

special instructions are: avoid food 2hrs before and after taking in particular calcium-containing products

side effects include severe allergic reactions such as drug rash with eosinophilia and systemic symptoms (DRESS). Signs are rash/fever/swollen glands or increased white cell count

dose is 2g once daily

23
Q

describe specialist treatment: denosumab

A

treatment option fro the 1 prevention of osteoporotic of the following apply:

  1. postmenopausal women at increased risk of osteoporosis
  2. Unable to comply with special instructions for administering alendronate/risedronate/etidronate
  3. Intolerances or Contra indications to the above
  4. Can be used in pts who have a combination of T-score with age and no. of independent clinical risk factors for #